Ophthalmology Times Europe eNews:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  TOP SEARCHES: OCT // Canaloplasty // AMD
 
 
OCTOBER 8, 2009

IN THIS ISSUE
Glaucoma gene identified
Retinal macroaneurysm
SLT after maximum tolerated drug therapy
Three new ophthalmic solutions
Gene variant linked to glaucoma identified
Researchers have discovered gene variants for glaucoma in a black population which could help progress tests for early diagnosis. More...
Spontaneous resolution of a retinal macroaneurysm
Regression of a retinal macroaneurysm and sub-retinal haemorrhage with serial OCT images: a case report by Dr Khadijah Basheer. More...
SLT in patients with insufficient control of IOP under maximum tolerated drug therapy
Drs Hirn, Zweifel and Funk look at whether additional IOP reduction occurs when SLT is applied and if so, how long it is maintained. More...
Three solutions to support entire treatment spectrum
At the recent ESCRS congress in Barcelona Carl Zeiss Meditec showcased three new ophthalmic treatment solutions designed to work together to improve productivity, workflow and outcomes. More...

Also in this issue
Improving retinal examination speed and efficiency
EyeBag compress
Eyetooth implant restores vision
Retinal prosthesis
ESCRS highlights
Coherent achieves ISO 13485 in Goettingen
Cataract surgery can offer major benefits to AMD patients


Survey

Do you calculate ocular perfusion pressure in patients with glaucoma?


You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Amelia Tope, associate editor.

Click here to contact Neil Hanley, sales manager.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.